UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
3 Korean startups using AI to develop new drugs
by Marian Chu
2017-12-15 23:00
Corestem’s NeuroNata-R marks increase in foreign patients
by Lee Han-soo
2017-12-15 16:22
Critical care for sepsis limited in Korea despite high mortality
by Kwak Sung-sun
2017-12-15 15:39
Medytox, Hugel compete in botulinum toxin market
by So Jae-hyeon
2017-12-15 15:12
Korea, China agree to cooperate on healthcare
by Lee Han-soo
2017-12-15 14:24
라인
Parkinson’s disease treatment Azilect in robust growth
by So Jae-hyeon
2017-12-15 11:36
60% approve expanded health coverage, oppose higher premiums: survey
by Marian Chu
2017-12-14 17:45
FDA approves Pfizer’s Remicade biosimilar
by Lee Han-soo
2017-12-14 17:16
Korea launches mobile hospital to deploy emergency medical aid
by Marian Chu
2017-12-14 16:56
Hironic wins ministry certification for Q-Fit
by Lee Han-soo
2017-12-14 15:14
라인
University professors sign petition against abortion law
by Marian Chu
2017-12-14 15:03
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market
by Lee Hye-seon
2017-12-14 15:01
‘More accurate diagnosis of preeclampsia possible’
by Park Gi-taek
2017-12-14 11:38
‘New cancer drugs need 601 days to get insurance in Korea’
by So Jae-hyeon
2017-12-14 11:27
Samsung BioLogics’ 2nd factory gets European approval
by Lee Han-soo
2017-12-14 10:52
라인
Koreans in their 20s most susceptible to hepatitis A: study
by Marian Chu
2017-12-13 18:18
MGmed to change name to Cancer Rop
by Marian Chu
2017-12-13 18:14
[Column] Look ahead 10 years before investing
by Song Hyoung-gon
2017-12-13 17:48
Syntekabio, CJ Healthcare agree to develop new drugs using AI
by Lee Han-soo
2017-12-13 17:17
Daewoong’s liver drug Ursa to enter US market
by So Jae-hyeon
2017-12-13 15:23
-
이전
251
252
253
254
255
256
257
258
259
260
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top